Matthew Buten - Chief Financial Officer at Biohaven Pharmaceutical Holding Co Ltd.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
BHVN
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew Buten since 12/17/2023

Holdings reported by Matthew Buten for Biohaven Pharmaceutical Holding Co Ltd.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 0 $148.50 Oct 3, 2022 Direct
Restricted Share Unit Award 0 Oct 3, 2022 Direct Common Shares
Stock Options (Right to Buy) 0 Oct 3, 2022 Direct Common Shares

Transactions reported by Matthew Buten for Biohaven Pharmaceutical Holding Co Ltd.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.